rs11728471

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001083619.3(GRIA2):​c.2044-8268C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.075 in 152,220 control chromosomes in the GnomAD database, including 573 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.075 ( 573 hom., cov: 32)

Consequence

GRIA2
NM_001083619.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0260

Publications

1 publications found
Variant links:
Genes affected
GRIA2 (HGNC:4572): (glutamate ionotropic receptor AMPA type subunit 2) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. This gene product belongs to a family of glutamate receptors that are sensitive to alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA), and function as ligand-activated cation channels. These channels are assembled from 4 related subunits, GRIA1-4. The subunit encoded by this gene (GRIA2) is subject to RNA editing (CAG->CGG; Q->R) within the second transmembrane domain, which is thought to render the channel impermeable to Ca(2+). Human and animal studies suggest that pre-mRNA editing is essential for brain function, and defective GRIA2 RNA editing at the Q/R site may be relevant to amyotrophic lateral sclerosis (ALS) etiology. Alternative splicing, resulting in transcript variants encoding different isoforms, (including the flip and flop isoforms that vary in their signal transduction properties), has been noted for this gene. [provided by RefSeq, Jul 2008]
GRIA2 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with language impairment and behavioral abnormalities
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, G2P, Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.114 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRIA2NM_001083619.3 linkc.2044-8268C>T intron_variant Intron 12 of 15 ENST00000264426.14 NP_001077088.2 P42262-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRIA2ENST00000264426.14 linkc.2044-8268C>T intron_variant Intron 12 of 15 1 NM_001083619.3 ENSP00000264426.9 P42262-1

Frequencies

GnomAD3 genomes
AF:
0.0750
AC:
11402
AN:
152102
Hom.:
572
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0172
Gnomad AMI
AF:
0.194
Gnomad AMR
AF:
0.0569
Gnomad ASJ
AF:
0.109
Gnomad EAS
AF:
0.00232
Gnomad SAS
AF:
0.120
Gnomad FIN
AF:
0.146
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.102
Gnomad OTH
AF:
0.0674
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0750
AC:
11413
AN:
152220
Hom.:
573
Cov.:
32
AF XY:
0.0770
AC XY:
5729
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.0171
AC:
712
AN:
41554
American (AMR)
AF:
0.0569
AC:
871
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.109
AC:
378
AN:
3466
East Asian (EAS)
AF:
0.00232
AC:
12
AN:
5168
South Asian (SAS)
AF:
0.122
AC:
589
AN:
4826
European-Finnish (FIN)
AF:
0.146
AC:
1547
AN:
10584
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.102
AC:
6967
AN:
68002
Other (OTH)
AF:
0.0662
AC:
140
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
530
1059
1589
2118
2648
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
144
288
432
576
720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0866
Hom.:
130
Bravo
AF:
0.0646
Asia WGS
AF:
0.0590
AC:
204
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
2.0
DANN
Benign
0.20
PhyloP100
-0.026
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11728471; hg19: chr4-158272780; API